Xianmei Qi

State Key Laboratory Of Common Mechanism Research For Major Disease, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Spatially Resolved Metabolomics Reveals Metabolic Heterogeneity Among Pulmonary Fibrosis.

Spatially Resolved Metabolomics Reveals Metabolic Heterogeneity Among Pulmonary Fibrosis.

Journal: Journal of mass spectrometry : JMS
Published: November 27, 2024

xCT/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPKα suppression of mTOR activation.

xCT/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPKα suppression of mTOR activation.

Journal: Biochemical pharmacology
Published: June 22, 2024

Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.

Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.

Journal: Circulation
Published: February 05, 2024

Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension.

Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension.

Journal: Acta pharmaceutica Sinica. B
Published: August 09, 2023

Proteome, Lysine Acetylome, and Succinylome Identify Posttranslational Modification of STAT1 as a Novel Drug Target in Silicosis.

Proteome, Lysine Acetylome, and Succinylome Identify Posttranslational Modification of STAT1 as a Novel Drug Target in Silicosis.

Journal: Molecular & cellular proteomics : MCP
Published: July 09, 2023

Inhibition of immunoglobulin E attenuates pulmonary hypertension.

Inhibition of immunoglobulin E attenuates pulmonary hypertension.

Journal: Nature cardiovascular research
Published: October 31, 2021

Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis.

Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis.

Journal: Acta pharmaceutica Sinica. B
Published: June 28, 2021

Comparative Transcriptome Analyses Reveal a Transcriptional Landscape of Human Silicosis Lungs and Provide Potential Strategies for Silicosis Treatment.

Comparative Transcriptome Analyses Reveal a Transcriptional Landscape of Human Silicosis Lungs and Provide Potential Strategies for Silicosis Treatment.

Journal: Frontiers in genetics
Published: January 13, 2021

Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.

Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.

Journal: Experimental cell research
Published: July 02, 2020

Multi-omics study of silicosis reveals the potential therapeutic targets PGD2 and TXA2.

Multi-omics study of silicosis reveals the potential therapeutic targets PGD2 and TXA2.

Journal: Theranostics
Published: April 30, 2020

A novel pathophysiological classification of silicosis models provides some new insights into the progression of the disease.

A novel pathophysiological classification of silicosis models provides some new insights into the progression of the disease.

Journal: Ecotoxicology and environmental safety
Published: March 26, 2020

Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin.

Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin.

Journal: Thorax
Published: March 22, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026